Development Level

Tbio 109 | 10,625
Tchem 11 | 1,890
Tclin 6 | 602
Tdark 4 | 7,003

IMPC Term

decreased T cell number 1 | 31
decreased heart weight 1 | 44
decreased monocyte cell number 1 | 28
increased CD4-positive, alpha ... 1 | 15
increased leukocyte cell numbe... 1 | 37

Disease

Cancer 88 | 2,346
diabetes mellitus 78 | 1,663
Hypersensitivity reaction type II disease 75 | 235
Ankylosing spondylitis 71 | 138
psoriasis 67 | 6,685
Juvenile rheumatoid arthritis 63 | 105
Rheumatoid Arthritis 63 | 1,171
Acquired immunodeficiency syndrome 61 | 164
Arthritis 61 | 248
Uveitis 61 | 103
Behcet's disease 56 | 74
Human immunodeficiency virus infectious disease 56 | 129
Psoriatic arthritis 53 | 85
Stevens-Johnson syndrome 52 | 91
Dermatitis 45 | 141
Multiple Sclerosis 44 | 498
dermatomyositis 44 | 967
Behcet's syndrome 37 | 50
Synovitis 36 | 72
Congenital adrenal hyperplasia 35 | 74
Nephritis 35 | 63
Retinal vasculitis 35 | 36
Spondyloarthropathy, Susceptibility To, 1 35 | 35
Takayasu's arteritis 35 | 54
drug-induced hepatitis 35 | 44
Hepatitis B 33 | 103
Anemia 28 | 252
Kidney disease 28 | 397
Leprosy 28 | 77
Liver disease 28 | 219
Primary immunodeficiency disease 26 | 52
Skin disease 23 | 65
Hemochromatosis 22 | 55
Birdshot chorioretinopathy 21 | 23
lung cancer 21 | 4,473
lung carcinoma 20 | 2,844
sarcoidosis 19 | 368
systemic lupus erythematosus 18 | 172
Berylliosis 16 | 28
Narcolepsy 16 | 69
glioblastoma 16 | 5,572
ovarian cancer 16 | 8,492
Asthma 15 | 349
Human immunodeficiency virus type 1, susceptibility to 15 | 26
osteosarcoma 15 | 7,933
pre-eclampsia 15 | 67
tuberculosis 15 | 1,563
Multiple Sclerosis, Susceptibility to 14 | 15
Narcolepsy-cataplexy 14 | 21
Psoriasis susceptibility 1 14 | 14
cutaneous lupus erythematosus 14 | 1,056
interstitial cystitis 14 | 2,299
Diffuse cutaneous systemic sclerosis 13 | 17
Rheumatoid Arthritis, Systemic Juvenile 13 | 16
Sarcoidosis 1 13 | 14
follicular lymphoma 13 | 17
limited scleroderma 13 | 19
pilocytic astrocytoma 13 | 3,086
primary Sjogren syndrome 13 | 789
subependymal giant cell astrocytoma 13 | 2,287
Influenza 11 | 142
invasive ductal carcinoma 11 | 2,950
non-small cell lung cancer 11 | 2,798
Type 1 diabetes mellitus 10 | 104
active Crohn's disease 10 | 918
breast carcinoma 10 | 1,614
Allergic hypersensitivity disease 9 | 123
Celiac disease 9 | 112
Graves' disease 9 | 25
astrocytoma 9 | 1,493
juvenile dermatomyositis 9 | 1,189
posterior fossa group A ependymoma 9 | 1,511
Autistic Disorder 8 | 320
Autoimmune thyroiditis 8 | 24
Duchenne muscular dystrophy 8 | 602
Hepatitis 8 | 61
Hypersensitivity 8 | 63
Inflammatory bowel disease 8 | 142
Tetanus 8 | 66
adult high grade glioma 8 | 2,148
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,988
ulcerative colitis 8 | 2,087
Hepatitis B, Chronic 7 | 15
Hepatitis C 7 | 90
Leishmaniasis 7 | 49
Multiple myeloma 7 | 1,328
Vasculitis 7 | 64
active ulcerative colitis 7 | 477
head and neck cancer and chronic obstructive pulmonary disease 7 | 237
malignant mesothelioma 7 | 3,163
Drug allergy 6 | 36
Drug-Induced Liver Injury 6 | 118
Eosinophilia 6 | 65
Hypothyroidism 6 | 89
Leukopenia 6 | 42
Thrombocytopenia 6 | 105
Thyrotoxicosis 6 | 38
colon cancer 6 | 1,475
esophageal adenocarcinoma 6 | 737
limb girdle muscular dystrophy 2I 6 | 56

Tissue

Nervous System 58 | 18,561
Female tissues 57 | 18,647
Digestive Tract 56 | 18,473
Urinary Tract 56 | 18,444
Blood and immune system 52 | 17,995
Endocrine System 52 | 18,512
Cardiovascular System 50 | 17,958
Liver and Pancreas 49 | 18,136
Respiratory system 49 | 17,484
Male tissues 47 | 17,969
Skin and soft tissues 44 | 18,115

Target Family

Non-IDG 127 | 11,969
Enzyme 2 | 4,146
GPCR 1 | 408

KEGG Pathway

Autoimmune thyroid disease 130 | 130
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
HLA class I histocompatibility antigen, alpha chain G HLA-G Tbio Non-IDG -3.07995 1275.9 729
HLA class II histocompatibility antigen, DP beta 1 chain HLA-DPB1 Tbio Non-IDG -2.67719 572.7 274
HLA class I histocompatibility antigen, A-3 alpha chain HLA-A Tbio Non-IDG -2.40709 4042.7 585
Cytotoxic T-lymphocyte protein 4 CTLA4 Tclin Non-IDG -3.53985 3564.0 656
HLA class I histocompatibility antigen, A-80 alpha chain HLA-A Tbio Non-IDG -2.40709 4042.7 0
CD40 ligand CD40LG Tchem Non-IDG -4.56976 36580.5 1095
HLA class I histocompatibility antigen, B-35 alpha chain HLA-B Tbio Non-IDG -1.87358 1568.8 0
Thyrotropin receptor TSHR Tclin GPCR -3.01423 1127.2 380
HLA class II histocompatibility antigen, DRB1-14 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 337
Tumor necrosis factor ligand superfamily member 6 FASLG Tchem Non-IDG -3.52437 3494.0 818